Parallel Advisors’s Insmed INSM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$375K Buy
2,291
+266
+13% +$40.9K 0.01% 841
2025
Q4
$352K Buy
2,025
+44
+2% +$8.03K 0.01% 827
2025
Q3
$285K Buy
1,981
+17
+0.9% +$2.08K 0.01% 891
2025
Q2
$198K Buy
1,964
+27
+1% +$2.06K ﹤0.01% 1022
2025
Q1
$148K Sell
1,937
-53
-3% -$4.05K ﹤0.01% 1090
2024
Q4
$137K Buy
1,990
+76
+4% +$5.47K ﹤0.01% 1113
2024
Q3
$140K Buy
1,914
+40
+2% +$2.95K ﹤0.01% 1100
2024
Q2
$126K Buy
1,874
+1,143
+156% +$44.3K ﹤0.01% 1073
2024
Q1
$19.8K Buy
731
+96
+15% +$2.69K ﹤0.01% 1984
2023
Q4
$19.7K Buy
635
+329
+108% +$8.53K ﹤0.01% 1957
2023
Q3
$7.73K Buy
+306
New +$7K ﹤0.01% 2320
2022
Q4
Sell
-28
Closed -$1K 3440
2022
Q3
$1K Buy
28
+23
+460% +$551 ﹤0.01% 2935
2022
Q2
$0 Buy
+5
New +$105 ﹤0.01% 3159
2022
Q1
Sell
-119
Closed -$3K 3108
2021
Q4
$3K Buy
119
+25
+27% +$715 ﹤0.01% 2582
2021
Q3
$3K Hold
94
﹤0.01% 2570
2021
Q2
$3K Hold
94
﹤0.01% 2461
2021
Q1
$3K Hold
94
﹤0.01% 2374
2020
Q4
$3K Hold
94
﹤0.01% 2205
2020
Q3
$3K Hold
94
﹤0.01% 2190
2020
Q2
$2K Buy
+94
New +$2.23K ﹤0.01% 2197
2019
Q4
Sell
-41
Closed -$1K 2444
2019
Q3
$1K Hold
41
﹤0.01% 2283
2019
Q2
$1K Buy
+41
New +$1.14K ﹤0.01% 2200

Other funds holding INSM

Parallel Advisors's INSM Position: Q1 2026 in Review

Parallel Advisors increased its Insmed (INSM) stake by 13% in Q1 2026, buying an estimated $40.9K and bringing the position to 2,291 shares worth $375K. The position accounts for 0.01% of the portfolio, ranked #841.

Parallel Advisors first reported a position in INSM in Q2 2019 and has held it in 22 quarters since. 669 funds tracked by Wall St. Rank hold INSM as of Q1 2026.

  • Parallel Advisors held 2,291 shares of Insmed worth $375K as of Q1 2026.
  • Parallel Advisors bought 266 Insmed shares in Q1 2026, an estimated $40.9K.
  • Insmed made up 0.01% of Parallel Advisors's portfolio in Q1 2026, its #841 holding.
  • Parallel Advisors first reported a position in Insmed in Q2 2019 and has held it in 22 quarters since.
  • 669 funds tracked by Wall St. Rank held Insmed as of Q1 2026.

Based on Parallel Advisors's 13F filing for Q1 2026, filed 7 May 2026.